Volume 12, Number 11—November 2006
Letter
Chikungunya Fever, Hong Kong
Nelson Lee*, Chun K. Wong*, Wai Y. Lam*, Ann Wong†, Wilina Lim†, Christopher W.K. Lam*, Clive S. Cockram*, Joseph J.Y. Sung*, Paul K.S. Chan*, and Julian W. Tang*
Table
Serum cytokine profiles of patient with chikungunya infection, days 2 and 6 of illness*
| Serum cytokine profile (ng/L) | Time after onset of illness | |
|---|---|---|
| 2 d | 6 d | |
| IFN-γ, N<15.6 | UD | UD |
| IL-1β, N<7.2 | 2.4 | 1.5 |
| IL-6, N<3.1 | UD | 1.3 |
| IL-10, N<7.8 | 1.7 | 1.7 |
| IL-12 p70, N<7.8 | 3.6 | 1.4 |
| TNF-α, N<10.0 | UD | UD |
| CXCL8, N<10.0 | 45.3 | 54.3 |
| CXCL10†, N = 232–1,019 | 26,319 | 16,156 |
| CCL2†, N = 18–152 | 445 | 257 |
| CXCL9†, N = 37–463 | 1,138 | 1,605 |
| CCL5, N = 10,349–46,704 | 24,745 | 60,671
*N, normal range; IFN, interferon; IL, interleukin; UD, undetected; TNF, tumor necrosis factor. *N, normal range; IFN, interferon; IL, interleukin; UD, undetected; TNF, tumor necrosis factor. |
*N, normal range; IFN, interferon; IL, interleukin; UD, undetected; TNF, tumor necrosis factor.
†Both 2 d and 6 d samples above normal range.
Page created: October 14, 2011
Page updated: October 14, 2011
Page reviewed: October 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.